Cisplatin
Cisplatin
Contact Us

We are here to help in anything you need. Please use our online system or send an email to .

Cisplatin

Inquiry
Catalog Number PR14913338
CAS 14913-33-8
Synonyms trans-Dichlorodiamineplatinum(II); azane;dichloroplatinum; Platinum, diamminedichloro-, (SP-4-1)-
IUPAC Name azane;dichloroplatinum
Molecular Weight 300.05
Molecular Formula Cl2H6N2Pt
InChI LXZZYRPGZAFOLE-UHFFFAOYSA-L
InChI Key InChI=1S/2ClH.2H3N.Pt/h2*1H;2*1H3;/q;;;;+2/p-2
Drug Categories Antineoplastic Agents; Antineoplastic and Immunomodulating Agents; BCRP/ABCG2 Substrates; Cardiotoxic antineoplastic agents; Chlorine Compounds; Cholinesterase Inhibitors; Compounds used in a research, industrial, or household setting; Cross-Linking Reagents; Cytochrome P-450 CYP2B6 Inhibitors; Cytochrome P-450 CYP2B6 Inhibitors (strength unknown); Cytochrome P-450 CYP2C9 Inhibitors; Cytochrome P-450 CYP2C9 Inhibitors (strength unknown); Cytochrome P-450 Enzyme Inhibitors; Drugs that are Mainly Renally Excreted; Drugs that are Mainly Renally Excreted with a Narrow Therapeutic Index; Immunosuppressive Agents; Indicators and Reagents; Laboratory Chemicals; Myelosuppressive Agents; Narrow Therapeutic Index Drugs; Nephrotoxic agents; Nitrogen Compounds; OCT2 Inhibitors; OCT2 Substrates; OCT2 Substrates with a Narrow Therapeutic Index; Platinum Compounds; Radiation-Sensitizing Agents
Drug Interactions Abacavir-Abacavir may decrease the excretion rate of Cisplatin which could result in a higher serum level.
Abatacept-The risk or severity of adverse effects can be increased when Cisplatin is combined with Abatacept.
Abciximab-The risk or severity of bleeding can be increased when Abciximab is combined with Cisplatin.
Acebutolol-Cisplatin may increase the bradycardic activities of Acebutolol.
Aceclofenac-Aceclofenac may decrease the excretion rate of Cisplatin which could result in a higher serum level.
Isomeric SMILES N.N.Cl[Pt]Cl
Type Small Molecule
Therapeutic Category Anticancer
Pharmacology

Indications

Cisplatin is primarily prescribed for the treatment of specific types of cancers, including metastatic testicular and ovarian tumors, as well as advanced bladder cancer. Its use in these conditions reflects its efficacy in targeting rapidly dividing cancer cells and hindering their proliferation.

Pharmacodynamics

As a member of the alkylating agent class, cisplatin serves as an antineoplastic agent effective in various cancer treatments. Alkylating agents function by introducing alkyl groups to various electronegative sites, interfering with cellular processes. Specifically, cisplatin cross-links guanine bases within DNA double-helix strands, impeding their ability to uncoil and separate, a crucial step for DNA replication. This disruption prevents cancer cells from successfully dividing. Additionally, these agents attach methyl or other alkyl groups inappropriately to molecules, leading to errors in base pairing and DNA miscoding. Although these agents do not target a specific phase of the cell cycle, they ultimately disrupt DNA function and induce cell death through multiple mechanisms.

Absorption

Upon administration of cisplatin at doses ranging from 20 to 120 mg/m², platinum concentrations are prominently detected in organs such as the liver, prostate, and kidney. Moderate levels are found in tissues like the bladder, muscle, testicle, pancreas, and spleen, with the lowest concentrations observed in the bowel, adrenal glands, heart, lungs, cerebrum, and cerebellum. Remarkably, platinum remains in these tissues for up to 180 days following the last dose, indicating a prolonged presence and potential for sustained therapeutic effects.

Mechanism of Action

Cisplatin operates through a multifaceted mechanism that primarily disrupts DNA function. First, it attaches alkyl groups to DNA bases, leading to fragmentation as repair enzymes fail to replace these alkylated bases, thereby hindering DNA synthesis and RNA transcription. Additionally, Cisplatin facilitates DNA damage by forming cross-links between DNA atoms, inhibiting the separation of DNA strands essential for replication and transcription processes. Furthermore, it induces nucleotide mispairing, ultimately causing mutations within the DNA sequence. Collectively, these actions effectively impede cell proliferation and promote apoptotic cell death.

It should be noted that our service is only used for research, not for clinical use.